Summary
Blood glucose and the responses of insulin and glucose-dependent insulinotropic polypeptide (GIP) were measured in 12 healthy, normal weight subjects after drinking 50g glucose. On a subsequent occasion each subject was given a simultaneous infusion of GIP and glucose to mimic the plasma concentrations observed in the first test. The peak GIP concentration after oral glucose was 22.3±1.9pmol/l (mean±SEM), but was higher after GIP infusion at 36.3±4.6pmol/l, (p<0.005). The blood glucose levels following oral glucose peaked at 6.3 ±0.5 mmol/l which'was the same as seen after intravenous glucose. The insulin response to oral glucose was, however, far higher (431.3±58.2pmol/l) than that obtained after GIP and glucose infusion (191.6 ±30.9 pmol/l, p<0.001). Thus it has not proved possible to explain completely the oral enhancement of insulin release by the action of GIP alone.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cleator IGM, Gourlay RH (1975) Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances. Am J Surg 13:128–135
Dupre J, Ross SA, Watson D, Brown JC (1973) Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol 37:826–828
Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R (1978) Oral glucose augmentation of insulin release. J Clin Invest 62:152–161
Creutzfeldt W (1979) The incretin concept today. Diabetologia 16:75–85
Sarson DL, Bryant MG, Bloom SR (1980) A radioimmunoassay of gastric inhibitory polypeptide in human plasma. J Endocrinol 85:487–496
Holohan KW, Murphy RF, Flanagan RWJ, Buchanan KD, Elmore DT (1973) Enzymatic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta 322:178–180
Alford FP, Bloom SR, Nabarro JDN (1977) Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay. Diabetologia 13:1–6
Elahi D, Andersen DK, Brown JC, Debas HT, Herschcopf RJ, Raizes RS, Tobin J, Andres R (1979) Pancreatic alpha and beta cell responses to gastric inhibitory polypeptide in normal man during controlled glycaemia. Am J Physiol 237:E185-E191
Brown JC, Dryburgh JR, Ross SA, Dupre J (1975) Identification and actions of gastric inhibitory polypeptide. Rec Progr Horm Res 31:487–532
BestermanHS, BloomSR, Sarson DL, Blackburn AM, Johnston DI, Patel HR, Stewart JS, Modigliani R, Guerin S, Mallinson CN (1978) Characteristic gut hormone profile in coeliac disease. Lancet 1:785–788
Crockett SE, Mazzaferri EL, Cataland S (1976) Gastric inhibitory polypeptide in maturity-onset diabetes mellitus. Diabetes 25:931–935
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sarson, D.L., Wood, S.M., Holder, D. et al. The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man. Diabetologia 22, 33–36 (1982). https://doi.org/10.1007/BF00253866
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00253866